254 related articles for article (PubMed ID: 27899193)
21. Associated malignancies in patients with Waldenström's macroglobulinemia and their kin.
Hanzis C; Ojha RP; Hunter Z; Manning R; Lewicki M; Brodsky P; Ioakimidis L; Tripsas C; Patterson CJ; Sheehy P; Treon SP
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):88-92. PubMed ID: 21454200
[TBL] [Abstract][Full Text] [Related]
22. Familial platelet disorder with propensity to acute myelogenous leukemia: genetic heterogeneity and progression to leukemia via acquisition of clonal chromosome anomalies.
Minelli A; Maserati E; Rossi G; Bernardo ME; De Stefano P; Cecchini MP; Valli R; Albano V; Pierani P; Leszl A; Sainati L; Lo Curto F; Danesino C; Locatelli F; Pasquali F
Genes Chromosomes Cancer; 2004 Jul; 40(3):165-71. PubMed ID: 15138996
[TBL] [Abstract][Full Text] [Related]
23. Detection of an activated JAK3 variant and a Xq26.3 microdeletion causing loss of PHF6 and miR-424 expression in myelodysplastic syndromes by combined targeted next generation sequencing and SNP array analysis.
Kunze K; Gamerdinger U; Leßig-Owlanj J; Sorokina M; Brobeil A; Tur MK; Blau W; Burchardt A; Käbisch A; Schliesser G; Kiehl M; Rosenwald A; Rummel M; Grimminger F; Hain T; Chakraborty T; Bräuninger A; Gattenlöhner S
Pathol Res Pract; 2014 Jun; 210(6):369-76. PubMed ID: 24674452
[TBL] [Abstract][Full Text] [Related]
24. GATA2 and secondary mutations in familial myelodysplastic syndromes and pediatric myeloid malignancies.
Wang X; Muramatsu H; Okuno Y; Sakaguchi H; Yoshida K; Kawashima N; Xu Y; Shiraishi Y; Chiba K; Tanaka H; Saito S; Nakazawa Y; Masunari T; Hirose T; Elmahdi S; Narita A; Doisaki S; Ismael O; Makishima H; Hama A; Miyano S; Takahashi Y; Ogawa S; Kojima S
Haematologica; 2015 Oct; 100(10):e398-401. PubMed ID: 26022708
[No Abstract] [Full Text] [Related]
25. Secondary myelodysplasia and acute leukemia in breast cancer patients after autologous bone marrow transplant.
Laughlin MJ; McGaughey DS; Crews JR; Chao NJ; Rizzieri D; Ross M; Gockerman J; Cirrincione C; Berry D; Mills L; Defusco P; LeGrand S; Peters WP; Vredenburgh JJ
J Clin Oncol; 1998 Mar; 16(3):1008-12. PubMed ID: 9508184
[TBL] [Abstract][Full Text] [Related]
26. [Next-generation sequencing and its application in acute myeloid leukemia and myelodysplastic syndrome].
Gu SC; Chang CK
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1545-9. PubMed ID: 22169322
[TBL] [Abstract][Full Text] [Related]
27. Identifying familial myelodysplastic/acute leukemia predisposition syndromes through hematopoietic stem cell transplantation donors with thrombocytopenia.
Churpek JE; Nickels E; Marquez R; Rojek K; Liu B; Lorenz R; Lepore J; Madzo J; Wickrema A; Artz AS; van Besien K; Godley LA
Blood; 2012 Dec; 120(26):5247-9. PubMed ID: 23258901
[No Abstract] [Full Text] [Related]
28. Myeloid Neoplasms with Germline Predisposition: A New Provisional Entity Within the World Health Organization Classification.
Czuchlewski DR; Peterson LC
Surg Pathol Clin; 2016 Mar; 9(1):165-76. PubMed ID: 26940275
[TBL] [Abstract][Full Text] [Related]
29. Therapy-related myelodysplastic syndrome.
Candelaria M; Dueñas-Gonzalez A
Expert Opin Drug Saf; 2015 May; 14(5):655-65. PubMed ID: 25675961
[TBL] [Abstract][Full Text] [Related]
30. Therapy-related myelodysplastic syndromes and acute leukemias.
Brusamolino E; Bernasconi C
Leukemia; 1992 Nov; 6 Suppl 4():23-5. PubMed ID: 1434826
[No Abstract] [Full Text] [Related]
31. Therapy-related leukemia and myelodysplastic syndrome: clinical, cytogenetic, and prognostic features.
Kantarjian HM; Keating MJ; Walters RS; Smith TL; Cork A; McCredie KB; Freireich EJ
J Clin Oncol; 1986 Dec; 4(12):1748-57. PubMed ID: 3783201
[TBL] [Abstract][Full Text] [Related]
32. [Haematological malignancies: incidence in Basse-Normandie, France, for 1997-2004].
Troussard X; Duchenet V; Cornet E; Mouchel D; Malet M; Collignon A
Rev Epidemiol Sante Publique; 2009 Jun; 57(3):151-8. PubMed ID: 19375876
[TBL] [Abstract][Full Text] [Related]
33. Secondary myelodysplastic syndromes and acute leukemias.
Zeidman A; Dayan DB; Mittelman M
Haematologia (Budap); 1995; 27(1):23-8. PubMed ID: 12051292
[TBL] [Abstract][Full Text] [Related]
34. Moderate increase of secondary hematologic malignancies after myeloablative radiochemotherapy and autologous stem-cell transplantation in patients with indolent lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group.
Lenz G; Dreyling M; Schiegnitz E; Haferlach T; Hasford J; Unterhalt M; Hiddemann W
J Clin Oncol; 2004 Dec; 22(24):4926-33. PubMed ID: 15611507
[TBL] [Abstract][Full Text] [Related]
35. Causal models of leukaemia and lymphoma.
Smith MT; Skibola CF; Allan JM; Morgan GJ
IARC Sci Publ; 2004; (157):373-92. PubMed ID: 15055307
[TBL] [Abstract][Full Text] [Related]
36. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
37. [p53 and hematologic malignancies].
Preudhomme C; Fenaux P
Pathol Biol (Paris); 1997 Dec; 45(10):898-908. PubMed ID: 9769955
[TBL] [Abstract][Full Text] [Related]
38. Recognizing familial myeloid leukemia in adults.
Nickels EM; Soodalter J; Churpek JE; Godley LA
Ther Adv Hematol; 2013 Aug; 4(4):254-69. PubMed ID: 23926458
[TBL] [Abstract][Full Text] [Related]
39. Clinical utility of gene panel-based testing for hereditary myelodysplastic syndrome/acute leukemia predisposition syndromes.
Guidugli L; Johnson AK; Alkorta-Aranburu G; Nelakuditi V; Arndt K; Churpek JE; Godley LA; Townsley D; Young NS; Fitzpatrick C; Del Gaudio D; Das S; Li Z
Leukemia; 2017 May; 31(5):1226-1229. PubMed ID: 28104920
[No Abstract] [Full Text] [Related]
40. Introduction to cancer genetic susceptibility syndromes.
McGee RB; Nichols KE
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):293-301. PubMed ID: 27913494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
